US regulators sent seemingly mixed messages this month about the outlook for animal-derived, or desiccated, thyroid medicines ...

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie has recently completed a Phase 3b clinical ...

AbbVie has performed better than the market over the past decade. The company has lost a major product, but its lineup and ...

AbbVie and Genmab’s epcoritamab has shown promise as part of a combination treatment for relapsed or refractory follicular ...

The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.

AbbVie has announced a USD 195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic ...

AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...

On May 12, Trump signed an executive order stating that U.S. consumers are being overcharged for prescription drugs and that ...

In vivo CAR T-cell therapies promise to revolutionize cancer treatment, enhancing access and reducing costs while addressing ...

A large trial in a primary care setting found daily emollient use to be safe, feasible, and effective in reducing atopic ...